NEW YORK, Jan. 26 (UPI) -- Drugmaker Pfizer announced Monday it had reached a $68 billion cash-and-stock agreement to merge with U.S. rival Wyeth.
SOUTH SAN FRANCISCO, Calif., May 8 (UPI) -- U.S. pharmaceutical company Pfizer Inc. will spend $25 million on a Monogram Bioscience Inc. bond and help MBI globally market its Co-Receptor Tropism Assay.
LINCOLN, Neb., April 27 (UPI) -- U.S. pharmaceutical maker Pfizer Inc. says it has more than 150 new medicines in development and more than 80 other projects underway. Pfizer chief executive officer Hank McKinnel told shareholders Thursday at a Nebraska meeting that the world's biggest d
SEOUL, April 19 (UPI) -- Pfizer Inc. is closing its Seoul pharmaceutical plant, a facility that makes the hypertension drug Norvasc.
LITTLE FALLS, N.J., Feb. 13 (UPI) -- The consumer business of big U.S. pharmaceutical Pfizer Inc. is worth between $10 billion to $15 billion, a consulting firm says.
NEW YORK, Dec. 27 (UPI) -- Pfizer Inc. has taken a $50 million, 12-percent stake in California-based Perlegen Sciences Inc., a DNA analysis firm.
WILMINGTON, Del., Dec. 19 (UPI) -- Pfizer Inc. has scored a legal victory against India's Ranbaxy Laboratories Ltd., pushing a global effort annul patent protections from Lipitor.
NEW YORK, Nov. 22 (UPI) -- New York-based Pfizer Inc. continued its string of legal victories against India's Ranbaxy Pharmaceuticals Inc., a generic drug maker.
WASHINGTON, Sept. 14 (UPI) -- The U.S. Food and Drug Administration rejected Pfizer Inc.'s application to market Oporia, a pill to treat osteoporosis, without explanation.
NEW YORK, June 16 (UPI) -- Pfizer Inc., the giant drugmaker, will pay about $1.9 billion to buy Pennsylvania's Vicuron Pharmaceuticals Inc., the companies said Thursday.
